BRIEF published on 07/17/2026 at 00:05, 3 months 24 days ago Lumibird en négociations exclusives pour vendre sa division médicale à IPG Photonics Croissance Stratégique IPG Photonics Groupe Lumibird Vente De La Division Médicale Focus Sur La Photonique
BRIEF published on 07/17/2026 at 00:05, 3 months 24 days ago Exclusive negotiations: Lumibird sells its medical division Transfer Photonics LUMIBIRD Medical Division IPG Photonics
BRIEF published on 07/17/2026 at 00:05, 3 months 24 days ago LIR Life Sciences Partners with Oxygen Handel for Regulatory Roadmap Obesity Treatment Transdermal Delivery Development Agreement GLP-1 Therapeutics Regulatory Roadmap
BRIEF published on 07/17/2026 at 00:05, 3 months 24 days ago LIR Life Sciences s'associe à Oxygen Handel pour une feuille de route réglementaire Traitement De L'obésité Administration Transdermique Accord De Développement Thérapeutiques GLP-1 Feuille De Route Réglementaire
BRIEF published on 07/16/2026 at 23:15, 3 months 24 days ago Marinomed Biotech AG Seeks Court-Approved Restructuring Amid Financial Strains Marinomed Biotech AG Financial Stability Insolvency Risk Unither Pharmaceuticals Court Restructuring
BRIEF published on 07/16/2026 at 23:15, 3 months 24 days ago Marinomed Biotech AG demande une restructuration approuvée par le tribunal en raison de difficultés financières Marinomed Biotech AG Stabilité Financière Risque D'insolvabilité Unither Pharmaceuticals Restructuration Du Système Judiciaire
BRIEF published on 07/16/2026 at 22:15, 3 months 24 days ago DBV Technologies publie son Rapport Financier Semestriel 2026 Rapport Financier Cotation Boursière DBV Technologies Allergies Alimentaires Technologie VIASKIN
BRIEF published on 07/16/2026 at 22:15, 3 months 24 days ago DBV Technologies Files 2026 Half-Year Report with AMF Half-year Report AMF Filing DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 07/16/2026 at 22:15, 3 months 24 days ago DBV Technologies publishes its 2026 Half-Year Financial Report Financial Report Stock Market Listing DBV Technologies Food Allergies Viaskin Technology
BRIEF published on 07/16/2026 at 22:15, 3 months 24 days ago DBV Technologies dépose son rapport semestriel 2026 auprès d'AMF. Allergies Alimentaires Rapport Semestriel Dépôt AMF Technologies DBV Patch VIASKIN
Published on 11/10/2026 at 12:45, 23 minutes ago Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
Published on 11/10/2026 at 12:45, 23 minutes ago China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
Published on 11/10/2026 at 12:35, 33 minutes ago Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
Published on 11/10/2026 at 12:00, 1 hour 8 minutes ago High Tide Produces 67.3% Fe Direct Reduction Quality Concentrate from Labrador West Pilot Plant Program
Published on 11/10/2026 at 12:00, 1 hour 8 minutes ago Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
Published on 11/10/2026 at 12:50, 18 minutes ago Form 8.3 - Zürcher Kantonalbank: Irish Residential Properties REIT plc
Published on 11/10/2026 at 12:45, 23 minutes ago Gabler Group AG Invites to Earnings Call on Unaudited Q3 2026 Results
Published on 11/10/2026 at 12:35, 32 minutes ago Cognizant dedicates more than 25,000 professionals to Claude delivery, introduces managed services model to run Claude at the core of enterprise operations
Published on 11/10/2026 at 12:05, 1 hour 2 minutes ago EYKON is expanding the role of the meter at the grid edge
Published on 11/10/2026 at 12:05, 1 hour 2 minutes ago EYKON launches Orkestra, a new software platform for modern utility operations
Published on 11/10/2026 at 11:02, 2 hours 5 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 2 hours 5 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 6 hours 8 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 6 hours 8 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 18 hours 38 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
